PG

US consumer staple companies likely faced another "tricky" quarter, with earnings growth seen impact

With a market cap of $345.5 billion, The Procter & Gamble Company (PG) is a global leader in branded consumer packaged goods, offering a wide range of products across five key segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. P&G markets its products through various retail and professional channels worldwide. The Cincinnati, Ohio-based company is set to announce its fiscal Q4 2026 results before the market opens on Wednesday, Jul. 29. Ahead of this event, analysts expect PG to report an adjusted EPS of $1.42, down 4.1% from $1.48 in the year-ago quarter. However, it has surpassed Wall Street's earnings estimates in each of the last four quarters. Dear Google Stock Fans, Mark Your Calendars for July 13 Oracle Stock Crashes to a 52-Week Low. Here’s Why It Might Be Time to Buy. Costco vs. Walmart: 1 Dividend-Paying Retail Giant Stands Above the Other Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For fiscal 2026, analysts predict the world's largest consumer products maker to post an adjusted EPS of $6.89, a marginal rise from $6.83 in fiscal 2025. Moreover, adjusted EPS is projected to grow 2.3% year-over-year to $7.05 in fiscal 2027. Shares of Procter & Gamble have declined nearly 5% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 20.3% return and the State Street Consumer Staples Select Sector SPDR ETF’s (XLP) 3.9% gain over the same period. Procter & Gamble rose 1.7% on Apr. 24 after reporting stronger-than-expected Q3 2026 results, with organic sales increasing 3%, ahead of the consensus, supported by 2% volume growth and 1% higher pricing, alongside broad-based growth across product categories and regions. The company also posted adjusted EPS of $1.59, beating the consensus and improving from $1.54 a year earlier, driven by particularly strong 7% organic sales growth in the beauty segment and high-single-digit growth in personal care. Analysts' consensus view on PG stock is cautiously optimistic, with an overall "Moderate Buy" rating. Among 26 analysts covering the stock, 10 recommend "Strong Buy," four suggest "Moderate Buy," and 12 advise "Hold." The average analyst price target is $163.25, indicating a potential upside of 11.9% from the current levels. O...

CINCINNATI, July 14, 2026--(BUSINESS WIRE)--The Board of Directors of The Procter & Gamble Company (NYSE:PG) declared a quarterly dividend of $1.0885 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 17, 2026 to Common Stock shareowners of record at the close of business on July 24, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareowners of record at the start of business on July 24, 2026. P&G has been paying a dividend for 136 consecutive years since its incorporation in 1890 and has increased its dividend for 70 consecutive years. This reinforces our commitment to return cash to shareowners, many of whom rely on the steady, reliable income earned with their investment in P&G. About Procter & Gamble P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news. Category: PG-IR View source version on businesswire.com: https://www.businesswire.com/news/home/20260714977463/en/ Contacts P&G Media Contact Henry Molski+1-513-622-1566 P&G Investor Relations Contact John Chevalier+1-513-983-9974

Procter & Gamble and Progressive are among the stocks that could rise after reporting earnings, according to Citi strategist Scott Chronert.

CINCINNATI, July 01, 2026--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) will webcast a discussion of its fourth quarter earnings results on Wednesday, July 29, 2026, beginning at 8:30 a.m. ET. Media and investors may access the live audio webcast at https://www.pginvestor.com. The webcast will also be available for replay. About Procter & Gamble P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news. Category: PG-IR View source version on businesswire.com: https://www.businesswire.com/news/home/20260701974641/en/ Contacts Media Contact:Henry Molski+1-513-505-3587

Colgate-Palmolive posted its fourth consecutive EPS beat, growing revenue 8% year over year while shares surged 16% year to date. P&G faces a $400 million tariff headwind and flat volume in key categories while shares have dropped 3% over the past year. Colgate commands 41% of global toothpaste market share, with Latin America revenue up 15% and free cash flow climbing 28% in Q1. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Colgate-Palmolive didn't make the cut. Grab the names FREE today. Procter & Gamble (NYSE:PG) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk. The internals tell a different story. P&G beat its most recent quarter, but the internals are softening under the polish. Management guided fiscal 2026 results toward the lower end of a $6.83 to $7.09 core EPS range while absorbing a $400 million after-tax tariff headwind and a $100 million commodity hit. Volume has gone quiet in Oral Care, Fabric Care, and Family Care, and the recent top-line gains have leaned on pricing and mix rather than units moving off shelves. That is the exact setup that invites private-label trade-downs when consumer budgets tighten, a risk flagged directly in the organic volume versus pure pricing dynamic going into 2026. The valuation does not pay you to wait through that. PG trades at a trailing PE of 22 with a 2.85% yield, and shares are down 3.46% over the past year while the broader market has run. This is the crowded mega-cap defensive trade, and the room is full. Colgate-Palmolive (NYSE:CL) just posted its fourth consecutive EPS beat, delivering adjusted EPS of $0.97 against a $0.9445 consensus, on revenue of $5.324 billion that grew 8.41% year over year. Shares are up 16.06% year to date while PG has lagged. Three reasons this gap widens from here. 1. The cash flow is accelerating. Operating cash flow jumped 24.5% to $747 million in Q1 2026, and free cash flow climbed 27.94% to $609 million. Full-year 2025 generated $3.634 billion in free cash and returned $3.033 billion to shareholders. The 60.6% gross profit margin gives Colgate the cushion to absorb input inflation without crimping earnings power. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Colgate-Palm...

Performance in Q1 was driven by a 12% sequential increase in PureFive production and the first-ever ahead-of-schedule completion of the Ironton turnaround, which tracked 15% below budget. Management attributes accelerating branded customer conversions to the convergence of high-quality FDA-grade material, regulatory mandates, and localized supply chains insulated from global disruptions. The macro environment has shifted from a headwind to a tailwind as rising virgin polypropylene prices and global supply chain volatility increase the relative value of PureCycle's domestic, waste-based feedstock. Strategic investment in on-site compounding reached mechanical completion in April, allowing the company to deliver application-ready products for film and thermoform without third-party reliance. The partnership with Procter & Gamble reached a critical milestone with final commercial approval for Tide and Vicks ZzzQuil applications, validating the technology against the industry's highest quality standards. Operating leverage is beginning to emerge as production grew 95% year-over-year while monthly operations spending remained relatively flat, increasing only 6%. Management expects a significant commercial ramp in the second half of 2026, supported by 40 million to 50 million pounds of annual application demand starting to ramp in Q2 and Q3. The resolution of New Jersey regulatory reviews is viewed as a major catalyst, with 25 million to 50 million pounds of volume contingent on approval as food contact exemptions sunset in early 2027. Global growth projects remain on track, with the Thailand facility targeting mechanical completion by late 2027 and the Belgium facility expecting permits by year-end 2026. Future application approvals for Procter & Gamble are expected to move considerably faster now that core specifications have been validated across the brand portfolio. The company maintains significant financing optionality through a $200 million undrawn revolving credit facility and approximately $273 million in potential warrant proceeds. Achieved the highest purity grade through CosPaTox testing, becoming the first recycler to produce resin pure enough for leave-on cosmetic packaging. The Ironton turnaround included over 170 projects targeting capacity and reliability, including a critical seal system replacement expected to materially improve long-term uptime...

Ironton turnaround completed ahead of schedule and under budget Record 8.4 million pounds of quarterly production Fifth consecutive quarter of sequential revenue growth Achieved final approval for commercialization of two Procter & Gamble (P&G) applications Macro environment is increasingly favorable as virgin resin prices rise significantly more than recycled feedstock costs ORLANDO, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT) (“PureCycle” or the “Company”), a U.S.-based company revolutionizing plastic recycling, today announced results for the first quarter ending March 31, 2026. First Quarter 2026 Highlights Operations Record quarter for production, surpassing the prior quarterly high; approximately 10 million pounds of feedstock throughput, also a new quarterly record On-site compounding mechanically complete in April; focused on producing PureFive Choice™ resin for polypropylene (“PP”) film and thermoform applications Ironton Facility turnaround completed ahead of schedule and tracking below budget; incorporated improvement projects targeting higher reliability, production rates, and product quality; product inventory built ahead of the outage to maintain customer shipments Commercial Fifth consecutive quarter of sequential revenue growth, with continued progress in the application pipeline and branded conversions across multiple product categories Reaffirming 40-50MM lbs. of demand beginning to ramp in Q2/Q3; 20-25MM lbs. of demand beginning to ramp in Q3/Q4 PureFive® resin passed qualification for first P&G application and slated for first pellet delivery in Q2; PureFive® resin passed qualification for second application and expected to ship in 2H 2026; Joint product quality study with P&G showed PureCycle process leads to highest CosPaTox purity rating New Jersey recycled content application is in review with NJ Department of Environmental Protection (NJDEP); continue to progress positive discussions with all levels of NJDEP and NJ government Macro Environment Global petrochemical supply disruption has increased both virgin resin and recycled feedstock costs; however, virgin PP prices have risen more than PureCycle’s feedstock costs, creating a more favorable environment for the pricing and marketability of recycled content Rising virgin resin prices are also expected to improve co-product pricing dynamics Growth...

This article first appeared on GuruFocus. Organic Sales Growth: Increased more than 3% versus the prior year. Volume Increase: Up 2 points. Pricing Increase: Up 1 point. Core Earnings Per Share (EPS): $1.59, up 3% versus prior year on a currency-neutral basis. Core Gross Margin: Down 100 basis points versus prior year. Core Operating Margin: Down 80 basis points versus prior year. Adjusted Free Cash Flow Productivity: 82%. Cash Returned to Shareholders: $3.2 billion, including $2.5 billion in dividends and over $600 million in share repurchases. Dividend Increase: Announced a 3% increase, marking the seventh consecutive annual increase. North America Organic Sales Growth: 4%. Europe Region Organic Sales Growth: 2%. Greater China Organic Sales Growth: 3%. Latin America Organic Sales Growth: 5%. Asia Pacific, Middle East, Africa Organic Sales Growth: 4%. Global Aggregate Market Share: Improved to in line with prior year. Guidance for Fiscal '26: Organic sales growth of in line to 4%, core EPS growth in line to 4%. Expected Cash Return to Shareholders for Fiscal '26: Approximately $15 billion. Warning! GuruFocus has detected 4 Warning Sign with APOG. Is PG fairly valued? Test your thesis with our free DCF calculator. Release Date: April 24, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Procter & Gamble Co (NYSE:PG) reported a solid acceleration in top-line results for the third quarter, with organic sales increasing by more than 3% compared to the previous year. The company achieved broad-based growth across all 10 product categories, with Skin and Personal Care growing in high single digits and Hair Care, Family Care, and Home Care growing mid-single digits. Geographically, organic sales grew in all seven regions, with North America seeing a 4% increase and Greater China achieving a 3% growth despite challenging consumer environments. Procter & Gamble Co (NYSE:PG) returned $3.2 billion of cash to shareholders this quarter, including $2.5 billion in dividends and over $600 million in share repurchases. The company announced a 3% increase in its dividend, marking the seventh consecutive annual dividend increase and the 136th consecutive year of dividend payments. Core gross margin was down 100 basis points, and core operating margin was down 80 basis points compared to the prior year, impacted by energy...

Friday, April 24th, 2026 Pre-market futures are off their early morning highs, but still mostly in positive territory. Cease-fire talks look promising, as Iran reportedly is sending negotiators to Pakistan and plans are for an Israel-Lebanon summit in the U.S. But the Strait of Hormuz remains closed, and even though Q1 earnings continue to come in strong, there remain plenty of question marks on the horizon. The Nasdaq is by far the outperformer among major indexes at this hour, +315 points or +1.17%, partly on strong Q1 numbers from Intel INTC yesterday after the close. The S&P 500 is +22 points, +0.31% and the small-cap Russell 2000 is +10, +0.37%. Only the blue-chip Dow is in the red currently: -70 points, -0.14%, largely on IBM’s IBM reported struggles in the software space in its earnings results yesterday. Procter & Gamble PG surpassed expectations on both top and bottom lines in its fiscal Q3 report this morning. Earnings of $1.59 per share beat the Zacks consensus by 3 cents, while revenues of $21.24 billion in the quarter outpaced estimates by +3.5%, and nicely ahead of the $19.78 billion reported in the year-ago quarter. For more on PG’s earnings, click here. Oilfield services major SLB SLB, formerly Schlumberger, beat estimates on its bottom line by a penny, and revenues of $8.32 billion were ahead of projections by +1.1%. But the high valuation of the stock (+42.6% year to date) is playing a factor in the stock’s -3.6% selloff ahead of the open. For more on SLB's earnings, click here. At 10am ET, the final print for U.S. Consumer Sentiment from the University of Michigan comes out. This highly respected metric saw an -11% drop month over month in the earlier release, to a record-low 47.6. Expectations are for this to bump up a percentage point or so, but still in relatively weak territory. Business conditions dropped -20% in the last report, while inflation expectations jumped +100 basis points (bps) to +4.8%. We look for these figures to moderate somewhat, as well, but the early stages of the Iran war were fraught with negative sentiment. We don’t expect revisions to completely erase this narrative. Q1 earnings season accelerates further next week, featuring results from Alphabet GOOGL, Amazon AMZN, Meta Platforms META and Microsoft MSFT, among many others — and these all on Tuesday afternoon. We’ll also see housing data from Case-Shiller and Ho...

The Procter & Gamble Company PG has delivered third-quarter fiscal 2026 results that topped the Zacks Consensus Estimate for both earnings and revenues and improved year over year. Results benefited from organic sales growth, driven by higher volume and pricing. From an earnings quality standpoint, the quarter reflected continued productivity savings across the P&L. Core operating income increased from the prior year after adjusting for incremental restructuring, even as the company absorbed mix pressure and incremental spending designed to support innovation and demand creation. Management maintained its fiscal 2026 outlook, but earnings are expected to trend toward the lower end of the range as cost headwinds persist and investments step up. Procter & Gamble’s core EPS of $1.59 per share rose 3% from the year-ago quarter and beat the Zacks Consensus Estimate of $1.56 by 1.9%. Currency-neutral core EPS of $1.54 was unchanged from last year, indicating that foreign exchange provided a meaningful tailwind to reported core per-share earnings growth in the period. Net sales increased 7% from the year-ago period to $21.24 billion, beating the consensus mark of $20.58 billion by 3.2%. PG’s reported net sales growth was supported by a favorable foreign exchange backdrop and steady underlying demand. Procter & Gamble Company (The) price-consensus-eps-surprise-chart | Procter & Gamble Company (The) Quote For the fiscal third quarter, total company net sales benefited from a 2% increase in volume, a 4% benefit from foreign exchange and a 1% gain from pricing, while mix was neutral. Organic sales advanced 3% from the prior year, reflecting the combination of higher unit volumes and pricing. Our model predicted year-over-year organic revenue growth of 2.4% for the third quarter of fiscal 2026, with 1.4% growth from pricing, a 0.7% rise in the product mix and a 0.4% gain in the organic volume. Category performance was broadly constructive. In the fiscal third quarter, Beauty posted net sales of $3.87 billion, up 11% year over year, with organic sales growth of 7%. Fabric & Home Care remained the largest contributor at $7.4 billion, up 7%, and delivered 3% organic sales growth. Baby, Feminine & Family Care generated $5.06 billion in sales, up 6%, with organic sales also up 3%. Health Care increased 7% to $3.07 billion, with organic sales growth of 2%. Grooming rose 7% to...

Procter & Gamble (PG) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.54 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +1.75%. A quarter ago, it was expected that this world's largest consumer products maker would post earnings of $1.87 per share when it actually produced earnings of $1.88, delivering a surprise of +0.53%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. P&G, which belongs to the Zacks Consumer Products - Staples industry, posted revenues of $21.24 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 3.52%. This compares to year-ago revenues of $19.78 billion. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. P&G shares have added about 1.7% since the beginning of the year versus the S&P 500's gain of 3.8%. While P&G has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for P&G was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Stron...